(Q42536167)

1 November 2017

Plasma and red blood cell fatty acids in peroxisomal disorders (English)

1 reference

1 November 2017

0 references

A B Moser

1

1 reference

1 November 2017

D S Jones

series ordinal

2

1 reference

1 November 2017

G V Raymond

series ordinal

3

1 reference

1 November 2017

H W Moser

series ordinal

4

1 reference

1 November 2017

1 February 1999

1 reference

1 November 2017

Neurochemical Research

1 reference

1 November 2017

24

1 reference

1 November 2017

2

1 reference

1 November 2017

187-197

1 reference

https://scigraph.springernature.com/pub.10.1023/a:1022549618333

1 November 2017

0 references

cites work

The Ratio of Trienoic: Tetraenoic Acids in Tissue Lipids as a Measure of Essential Fatty Acid Requirement

1 reference

12 December 2020

Abnormal profiles of polyunsaturated fatty acids in the brain, liver, kidney and retina of patients with peroxisomal disorders

1 reference

12 December 2020

Essential fatty acids in growth and development

1 reference

12 December 2020

Severe deficiency of docosahexaenoic acid in peroxisomal disorders: a defect of delta 4 desaturation?

1 reference

12 December 2020

Direct transesterification of plasma fatty acids for the diagnosis of essential fatty acid deficiency in cystic fibrosis.

1 reference

12 December 2020

Dietary erucic acid therapy for X-linked adrenoleukodystrophy

1 reference

12 December 2020

Polyunsaturated fatty acid changes suggesting a new enzymatic defect in Zellweger syndrome

1 reference

12 December 2020

Effects of long-chain, saturated fatty acids on membrane microviscosity and adrenocorticotropin responsiveness of human adrenocortical cells in vitro

1 reference

12 December 2020

The cerebro-hepato-renal (Zellweger) syndrome and other peroxisomal disorders

1 reference

12 December 2020

Direct transesterification of all classes of lipids in a one-step reaction

1 reference

12 December 2020

Lignoceric acid is oxidized in the peroxisome: implications for the Zellweger cerebro-hepato-renal syndrome and adrenoleukodystrophy

1 reference

12 December 2020

The cerebrohepatorenal (Zellweger) syndrome. Increased levels and impaired degradation of very-long-chain fatty acids and their use in prenatal diagnosis.

1 reference

12 December 2020

Phenotype of patients with peroxisomal disorders subdivided into sixteen complementation groups

1 reference

12 December 2020

Interactions of a very long chain fatty acid with model membranes and serum albumin. Implications for the pathogenesis of adrenoleukodystrophy

1 reference

12 December 2020

Fatty acid composition of plasma lipid classes in healthy subjects from birth to young adulthood

1 reference

12 December 2020

The gene responsible for adrenoleukodystrophy encodes a peroxisomal membrane protein

1 reference

12 December 2020

Blood polyunsaturated fatty acids in patients with peroxisomal disorders. A multicenter study

1 reference

12 December 2020

Docosahexaenoic acid--a new therapeutic approach to peroxisomal-disorder patients: experience with two cases

1 reference

12 December 2020

Putative X-linked adrenoleukodystrophy gene shares unexpected homology with ABC transporters

1 reference

12 December 2020

Dietary management of X-linked adrenoleukodystrophy

1 reference

12 December 2020

Disorders of peroxisome biogenesis

1 reference

12 December 2020

Plasma phospholipid fatty acids in X-linked adrenoleukodystrophy

1 reference

12 December 2020

Docosahexaenoic acid synthesis in human skin fibroblasts involves peroxisomal retroconversion of tetracosahexaenoic acid

1 reference

12 December 2020

Very long-chain fatty acids in diagnosis, pathogenesis, and therapy of peroxisomal disorders

1 reference

12 December 2020

Adrenoleukodystrophy: phenotype, genetics, pathogenesis and therapy

1 reference

12 December 2020

Fatty acid abnormality in adrenoleukodystrophy

1 reference

12 December 2020

Identifiers

DOI

10.1023/A:1022549618333

1 reference

Dimensions Publication ID

1 November 2017

0 references

1 reference